|

CBM588 Capsules Clinical Trials

1 actively recruiting trial across 1 location

Also known as: C. butyricum MIYAIRI 588, C. butyricum strain MIYAIRI 588, CBM588, Clostridium butyricum MIYAIRI 588

Pipeline

Phase 1: 1

Top Sponsors

  • Osel, Inc.1

Indications

  • Advanced Sarcomatoid Renal Cell Carcinoma1
  • Advanced Clear Cell Renal Cell Carcinoma1
  • Metastatic Sarcomatoid Renal Cell Carcinoma1
  • Metastatic Clear Cell Renal Cell Carcinoma1
  • Stage IV Renal Cell Cancer AJCC v81

Duarte, California1 trial

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.